All News

Nail, pitting, psoriasis, onycholysis

Impact of Nail Psoriasis on Psoriatic Arthritis

d Jack Cush, MD

Mease and colleagues have shown that psoriatic arthritis (PsA) patients with nail involvement have worse disease and outcomes than those without nail psoriasis.

Read Article
RheumNow Podcast square

RheumNow Podcast – What Not to Do (7.16.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
hip, OA, AVN

Osteonecrosis in Lupus

d Jack Cush, MD

A single center analysis of systemic lupus erythematosus (SLE) patients found symptomatic osteonecrosis (ON) in nearly 10%.

Read Article
JIA_0.jpg

Arthritis as a Harbinger of Pediatric Cancer

d Jack Cush, MD

Lancet Rheumatology has published a cohort analysis showing that a small but significant subset of children presenting with arthralgia or arthritis may have a pediatric malignancy.

Read Article
ANCA, vasculitis, test

ACR/Vasculitis Foundation 2021 Guidelines for ANCA–Associated Vasculitis

d Jack Cush, MD

Chung et al have published the 2021 treatment guielines for the management of antineutrophil cytoplasmic antibody–associated vasculitis, including granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. These guidelines are put forth by the ACR and the Vasculitis Foundation as benchmark guidance to assist health care professionals in managing AAV.  

Read Article
Knee corticosteroids injx within 4 wks of total joint arthroplasty may be assoc w/ a higher risk of postop infection (studies suggest a risk w/in 3 mos of TKA). Greatest risk seen w/in 2 wks of injx (OR 2.89), worse in <65 yrs & w/ comorbidities (RA) https://t.co/nZKTkv7ym5 https://t.co/4W6CNsrqpf

Links:

Dr. John Cush RheumNow ( View Tweet)
NEJM posts images of the malar rash, typical of #SLE. https://t.co/YZsnAXyhVX

Links:

Dr. John Cush RheumNow ( View Tweet)

Survey of women re: sex & reproduction (SRH) says women prefer 1) Rheums to initiate SRH discussions, 2) clear info on pregnancy & infertility risks w/ Dz & DMARDs, 3) holistic Rx approach, 4) not to be intermediaries betw Rheum & OB https://t.co/Orlh6gLO6P https://t.co/rS4r39Easx

Links:

Dr. John Cush RheumNow ( View Tweet)
Of 100 newly diagnosed #RA patients, Foot Involvement was the 1st manifestation in 29%. Pattern: 59% w/ forefoot involvement, 27% hindfoot and 14% midfoot. Pts were 58-63% RF+/CCP+. https://t.co/OGS2Fzfgg3 https://t.co/AKCj4pipYG

Links:

Dr. John Cush RheumNow ( View Tweet)
Very cool to see #RheumMadness in @ACRheum 🔥 #NephMadness —> #RheumMadness a “joint” venture Impressive work by @DavidLeverenz and entire team @LisaCriscione @GuyKatzMD @didemsayginmd @Allen06440733 RheumMadness: An Educational Tournament https://t.co/hHpm93C0yT https://t.co/ZPYxG6NUrl

Links:

Matthew Sparks, MD, FASN, FAHA Nephro_Sparks ( View Tweet)
ACR/Vasculitis Foundation 2021 Guidelines for ANCA–Associated Vasculitis Chung et al have published the 2021 treatment guidelines for the management of antineutrophil cytoplasmic antibody–AAV, including GPA, MPA, and EGPA. https://t.co/234OQ7klRd https://t.co/33sWq1U55T

Links:

Dr. John Cush RheumNow ( View Tweet)
Ann Int Med: 185 Hospitalized COVID-19 pts were treated with either PBO remdesivir or HCQ. Neither remdesivir nor HCQ affected viral clearance, Sxs duration, mortality or need for mechanical ventilation. https://t.co/NEFABDD4bK

Links:

Dr. John Cush RheumNow ( View Tweet)

Todays NEJM: Ruxolitinib effective in glucocorticoid-refractory Chronic Graft-versus-Host Dz. Phase 3, 329 pts; wk 24 responses better w/ RUX (50 vs 26%; P<0.001). Important? as there is phase 2 data showing JAK efficacy in scleroderma https://t.co/ygLevqfuMW

Links:

Dr. John Cush RheumNow ( View Tweet)

In 2016, 552,230 RA adults were hospitalized -1120 for influenza, 590 H zoster, & 785 for S. pneumoniae. These infections constituted 0.5% of RA hospitalizations at a cost of $124 million & 13,750 hosp stay days. https://t.co/7vtsWafGvv

Links:

Dr. John Cush RheumNow ( View Tweet)

2020 saw record numbers of drug overdose deaths (93,331) a big increase (29.4%) over 2019, according to CDC & Natl Center Health Statistics (NCHS). Overdose deaths 69,710 primarily fentanyl, Rx pain meds and cocaine https://t.co/K9GlWAeALS

Links:

Dr. John Cush RheumNow ( View Tweet)

Telehealth has declined but still much higher than pre-pandemic. CMS is proposing to extend Medicare coverage of certain telehealth services until the end of 2023. A -3.75% payment adjustment has been proposed & will be debated https://t.co/ETK74d9uGT

Links:

Dr. John Cush RheumNow ( View Tweet)

Metanalysis shows that Ustekinumab (effective in IBD) may also control skin and joint extra-intestinal manifestations. Despite no effect on spondylitis, UST was effective at PSO, PsA, pyoderma gangrenosum, E nodosum stomatitis and uveitis https://t.co/NPxJdYUM7I

Links:

Dr. John Cush RheumNow ( View Tweet)

Systematic review of muscle relaxants use in nonspecific low back pain shows uncertain, small, but not clinically important reductions in pain in the 1st 2weeks. Muscle relaxants are 3rd most common Rx for LBP (30 mill Rx in 2016)(49 trials >6505 pts) https://t.co/zN5rvBF1HO

Links:

Dr. John Cush RheumNow ( View Tweet)

Norwegian pre-pregnancy registry studied 274 axial SpA and 317 RA women. Longer time to pregnancy (TTP) seen in 21% (32% TTP >12 mos). Longer TTP associated with older age, nulliparity, and longer disease duration. https://t.co/kT7fqnhTkw https://t.co/8qC1N2K7vI

Links:

Dr. John Cush RheumNow ( View Tweet)
NHANES survey study shows adult psoriasis in the US was 3.0% (7.5 million adults). Psoriasis was most common in non-Hispanic White individuals, and the prevalence of psoriasis has not significantly changed since 2003 in the US. https://t.co/3yrlPu1GGi

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×